Downloaded from Bioscientifica.Com at 09/28/2021 06:30:55PM Via Free Access 480 TVA}NTTINEN and Others · Activin Regulation of Adrenal Cell Function

Total Page:16

File Type:pdf, Size:1020Kb

Downloaded from Bioscientifica.Com at 09/28/2021 06:30:55PM Via Free Access 480 TVA}NTTINEN and Others · Activin Regulation of Adrenal Cell Function 479 Expression of activin/inhibin signaling components in the human adrenal gland and the effects of activins and inhibins on adrenocortical steroidogenesis and apoptosis TVa¨nttinen1, J Liu2, T Kuulasmaa1, P Kivinen3 and R Voutilainen1,2 1Department of Pediatrics, Kuopio University and University Hospital, Kuopio, Finland 2Department of Pathology, Haartman Institute, University of Helsinki, Helsinki, Finland 3Department of Dermatology, Kuopio University and University Hospital, Kuopio, Finland (Requests for offprints should be addressed to R Voutilainen, Department of Pediatrics, Kuopio University Hospital, PO Box 1777, FIN-70211 Kuopio, Finland) Abstract Activins and inhibins are structurally related glycoprotein hydroxylase/17,20-lyase mRNA accumulation as evalu- hormones modulating pituitary FSH secretion and gonadal ated by the Northern blot technique, and decreased steroidogenesis. Activins and inhibins are also produced in cortisol, androstenedione, dehydroepiandrosterone and the adrenal cortex where their physiological role is poorly dehydroepiandrosterone sulfate secretion as determined known. Hormonally active human adrenocortical tumors by specific enzyme immunoassays. Activin A increased express and secrete inhibins, while in mice adrenal inhib- apoptosis as measured by a terminal deoxynucleotidyl ins may function as tumor suppressors. To clarify the transferase in situ apoptosis detection method. Inhibins had significance of adrenal activins and inhibins we investi- no effect on steroidogenesis or apoptosis. gated the localization of activin/inhibin signaling compo- In summary, activin/inhibin signaling components are nents in the adrenal gland, and the effects of activins and coexpressed in the zona reticularis and the innermost zona inhibins on adrenocortical steroidogenesis and apoptosis. fasciculata indicating full signaling potential for adrenal Activin receptor type II/IIB and IB, activin signal activins and inhibins in these layers. Activin inhibits transduction proteins Smad2/3, and inhibin receptor beta- steroidogenic enzyme gene expression and steroid secre- glycan were expressed throughout the adrenal cortex, tion, and increases apoptosis in human adrenocortical cells. whereas Smad4 expression was seen mainly in the zona Thus, the activin–inhibin system may have a significant reticularis and the innermost zona fasciculata as evaluated role in the regulation of glucocorticoid and androgen by immunohistochemistry. Treatment of cultured adreno- production and apoptotic cell death in the human adrenal cortical carcinoma NCI-H295R cells with activin A cortex. inhibited steroidogenic acute regulatory protein and 17- Journal of Endocrinology (2003) 178, 479–489 Introduction duction and apoptosis (reviewed in Woodruff 1998). Activins and inhibins are also produced in adrenal cells Activins and inhibins are members of the transforming (Voutilainen et al. 1991, Spencer et al. 1992, Voutilainen growth factor (TGF) superfamily of growth and 1995, Vänttinen et al. 2002). differentiation factors. They are structurally related glyco- In the adrenals, inhibins were originally suggested to be proteins composed of two of the three different subunits tumor-suppressor proteins on the basis that inhibin (A:A, A:B, B:B; activin A, activin AB and activin -subunit knockout mice developed malignant adrenal B; :A, :B; inhibin A and inhibin B respectively). tumors (Matzuk et al. 1994). However, later studies Gonads are the most important sources of inhibins in showed that inhibins do not have marked tumor- humans (reviewed in Vale et al. 1988, Ying 1988). suppressor activity in human adrenals, although loss of Gonadal inhibins suppress pituitary follicle-stimulating immunopositivity was reported in a subgroup of adreno- hormone secretion and stimulate ovarian theca cell andro- cortical carcinomas (Munro et al. 1999). In contrast, gen production (reviewed in Findlay 1993). Activins are increased inhibin -subunit mRNA and peptide expres- widely expressed and they have been shown to regulate a sion, and increased secretion of immunoreactive inhibins, variety of cell functions, including steroid hormone pro- were reported in virilizing and, to some extent, in Journal of Endocrinology (2003) 178, 479–489 Online version via http://www.endocrinology.org 0022–0795/03/0178–479 2003 Society for Endocrinology Printed in Great Britain Downloaded from Bioscientifica.com at 09/28/2021 06:30:55PM via free access 480 TVA}NTTINEN and others · Activin regulation of adrenal cell function cortisol-producing tumors (Nishi et al. 1995, Pelkey et al. kinase A activator, was used to mimic the effects of ACTH 1998, Arola et al. 2000, Vänttinen et al. 2002). on adrenocortical steroidogenesis as the NCI-H295R cell Adrenocorticotropin (ACTH) regulates adrenal line does not express functional ACTH receptors. inhibin/activin production suggesting that inhibins and activins may mediate or modulate the effects of ACTH in a para/autocrine manner (Voutilainen et al. 1991, Materials and Methods Vänttinen et al. 2002). ACTH regulates steroidogenesis at multiple levels. In addition to its acute effect on steroid Ethical considerations secretion, it increases the production of the steroidogenic acute regulatory protein (StAR) enabling the transport of The Research Ethics Committees of the Kuopio and cholesterol into mitochondria to be metabolized to steroid Helsinki University Hospitals approved the study proto- hormones (reviewed in Stocco 2001). ACTH stimulates cols, and the patients gave informed written consent. the synthesis of steroidogenic enzymes, including 17- hydroxylase/17,20-lyase (P450c17) essential for gluco- Immunohistochemistry corticoid and androgen production (reviewed in Miller 1988). The role of adrenal activins in the regulation of Normal adult adrenal tissues were obtained during surgery steroidogenesis is controversial; they have been shown to for renal tumors. Immunostaining was performed on stimulate ACTH-induced cortisol secretion in human fetal 5 µm sections cut from paraffin-embedded blocks of adrenal cells (Spencer et al. 1992), but to inhibit ACTH- paraformalin-fixed tissues. The sections were deparaffin- induced cortisol and dehydroepiandrosterone (DHEA) ized in xylene, rehydrated in a series of graded alcohols, secretion in bovine adrenal cells (Nishi et al. 1992). and permeabilized by microwaving at high power for Inhibins had no effects on adrenal steroidogenesis in these 5 min three times in citrate buffer (10 mM Na citrate, pH studies. 6·0). The sections were then washed in PBS and non- The signaling system of activins and inhibins in the specific staining was blocked with normal rabbit serum for adrenal gland is poorly characterized. Activins mediate at least 30 min at room temperature. Endogenous peroxi- their effects through specific receptors on cell membranes dase activities were blocked by 1% H2O2 for 30 min. The and via a cascade of cytosolic Smad proteins (reviewed in antigens in the sections were detected with corresponding Itoh et al. 2000, Pangas & Woodruff 2000). In brief, both affinity-purified goat polyclonal antibodies (ActRII/IIB, type I and II receptors (ActRI/IB and ActRII/IIB re- sc-5669; ActRIB, sc-11986, Smad2/3, sc-6032; Smad4, spectively), receptor-regulated Smads (R-Smads; Smad2 sc-1908, TGFRIII (G), sc-6199; all from Santa Cruz and Smad3) and a common-mediator Smad (Co-Smad; Biotechnology, Inc., Santa Cruz, CA, USA; and another Smad4) are needed for successful activin signaling. In TGFRIII antibody from Research Diagnostics, Inc., addition, inhibitory Smads (I-Smads; Smad6 and Smad7) Flanders, NJ, USA), which were applied at 1:100 dilution. regulate activin signaling. Inhibins, in turn, antagonize The primary antibodies were added on the adrenal sections activin signaling through binding to ActRII co-receptor in PBS, and incubation was performed overnight at 4 C. betaglycan (G, also known as TGF type III receptor; After this incubation, the slides were washed in PBS three reviewed in Gray et al. 2002). It is known that radiolabeled times. The primary antibodies were identified using activin and inhibin bind to rat adrenals and that activin and biotin-conjugated rabbit anti-goat IgG from an ABC-Elite inhibin receptor mRNAs are expressed in human adrenal Kit (PK-6105; Vector Laboratories, Inc., Burlingame, CA, cells (Woodruff et al. 1993, Vänttinen et al. 2002). USA), followed by incubation with ABC solution accord- Adrenocortical function is determined by both the ing to the manufacture’s instructions. Finally, light coun- number and the steroidogenic activity of the adrenocorti- terstaining was performed with hematoxylin, and the cal cells. The rate of cell proliferation and apoptosis sections were dehydrated and mounted. Each staining was contribute to the cell number. In this study we wanted to repeated with at least five different sections with similar shed more light on the role of activins and inhibins in the results. For the negative controls, the primary antibodies regulation of both adrenal steroidogenesis and apoptosis. were replaced by normal goat serum or PBS alone. To Activin and inhibin receptor and Smad signal transduction exclude the effect of possible endogenous biotin, biotin peptide localizations in the adrenal cortex were studied by blocking (avidin-biotin blocking kit; Vector Laboratories) immunohistochemistry. Human adrenocortical carcinoma was performed in two samples for each antigen detection cell line NCI-H295R, expressing all adrenal steroidogenic before the addition of the primary antibodies. enzymes,
Recommended publications
  • Immunoglobulin G Is a Platelet Alpha Granule-Secreted Protein
    Immunoglobulin G is a platelet alpha granule-secreted protein. J N George, … , L K Knieriem, D F Bainton J Clin Invest. 1985;76(5):2020-2025. https://doi.org/10.1172/JCI112203. Research Article It has been known for 27 yr that blood platelets contain IgG, yet its subcellular location and significance have never been clearly determined. In these studies, the location of IgG within human platelets was investigated by immunocytochemical techniques and by the response of platelet IgG to agents that cause platelet secretion. Using frozen thin-sections of platelets and an immunogold probe, IgG was located within the alpha-granules. Thrombin stimulation caused parallel secretion of platelet IgG and two known alpha-granule proteins, platelet factor 4 and beta-thromboglobulin, beginning at 0.02 U/ml and reaching 100% at 0.5 U/ml. Thrombin-induced secretion of all three proteins was inhibited by prostaglandin E1 and dibutyryl-cyclic AMP. Calcium ionophore A23187 also caused parallel secretion of all three proteins, whereas ADP caused virtually no secretion of any of the three. From these data and a review of the literature, we hypothesize that plasma IgG is taken up by megakaryocytes and delivered to the alpha-granules, where it is stored for later secretion by mature platelets. Find the latest version: https://jci.me/112203/pdf Rapid Publication Immunoglobulin G Is a Platelet Alpha Granule-secreted Protein James N. George, Sherry Saucerman, Shirley P. Levine, and Linda K. Knieriem Division ofHematology, Department ofMedicine, University of Texas Health Science Center, and Audie L. Murphy Veterans Hospital, San Antonio, Texas 78284 Dorothy F.
    [Show full text]
  • B Cell Activation and Escape of Tolerance Checkpoints: Recent Insights from Studying Autoreactive B Cells
    cells Review B Cell Activation and Escape of Tolerance Checkpoints: Recent Insights from Studying Autoreactive B Cells Carlo G. Bonasia 1 , Wayel H. Abdulahad 1,2 , Abraham Rutgers 1, Peter Heeringa 2 and Nicolaas A. Bos 1,* 1 Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, 9713 Groningen, GZ, The Netherlands; [email protected] (C.G.B.); [email protected] (W.H.A.); [email protected] (A.R.) 2 Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, 9713 Groningen, GZ, The Netherlands; [email protected] * Correspondence: [email protected] Abstract: Autoreactive B cells are key drivers of pathogenic processes in autoimmune diseases by the production of autoantibodies, secretion of cytokines, and presentation of autoantigens to T cells. However, the mechanisms that underlie the development of autoreactive B cells are not well understood. Here, we review recent studies leveraging novel techniques to identify and characterize (auto)antigen-specific B cells. The insights gained from such studies pertaining to the mechanisms involved in the escape of tolerance checkpoints and the activation of autoreactive B cells are discussed. Citation: Bonasia, C.G.; Abdulahad, W.H.; Rutgers, A.; Heeringa, P.; Bos, In addition, we briefly highlight potential therapeutic strategies to target and eliminate autoreactive N.A. B Cell Activation and Escape of B cells in autoimmune diseases. Tolerance Checkpoints: Recent Insights from Studying Autoreactive Keywords: autoimmune diseases; B cells; autoreactive B cells; tolerance B Cells. Cells 2021, 10, 1190. https:// doi.org/10.3390/cells10051190 Academic Editor: Juan Pablo de 1.
    [Show full text]
  • The Principles and Applications of Avidin-Based Nanoparticles in Drug Delivery and Diagnosis
    Journal of Controlled Release 245 (2017) 27–40 Contents lists available at ScienceDirect Journal of Controlled Release journal homepage: www.elsevier.com/locate/jconrel Review article The principles and applications of avidin-based nanoparticles in drug delivery and diagnosis Akshay Jain, Kun Cheng ⁎ Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri Kansas City, Kansas City, MO 64108, United States article info abstract Article history: Avidin-biotin interaction is one of the strongest non-covalent interactions in the nature. Avidin and its analogues Received 7 October 2016 have therefore been extensively utilized as probes and affinity matrices for a wide variety of applications in bio- Accepted 7 November 2016 chemical assays, diagnosis, affinity purification, and drug delivery. Recently, there has been a growing interest in Available online 16 November 2016 exploring this non-covalent interaction in nanoscale drug delivery systems for pharmaceutical agents, including small molecules, proteins, vaccines, monoclonal antibodies, and nucleic acids. Particularly, the ease of fabrication Keywords: Nanotechnology without losing the chemical and biological properties of the coupled moieties makes the avidin-biotin system a Avidin versatile platform for nanotechnology. In addition, avidin-based nanoparticles have been investigated as Neutravidin diagnostic systems for various tumors and surface antigens. In this review, we will highlight the various Streptavidin fabrication principles and biomedical applications of avidin-based nanoparticles in drug delivery and diagnosis. Non-covalent interaction The structures and biochemical properties of avidin, biotin and their respective analogues will also be discussed. Drug delivery © 2016 Elsevier B.V. All rights reserved. Imaging Diagnosis Contents 1. Introduction............................................................... 27 2. Biochemicalinsightsofavidin,biotinandanalogues............................................
    [Show full text]
  • How Does Protein Zero Assemble Compact Myelin?
    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 13 May 2020 doi:10.20944/preprints202005.0222.v1 Peer-reviewed version available at Cells 2020, 9, 1832; doi:10.3390/cells9081832 Perspective How Does Protein Zero Assemble Compact Myelin? Arne Raasakka 1,* and Petri Kursula 1,2 1 Department of Biomedicine, University of Bergen, Jonas Lies vei 91, NO-5009 Bergen, Norway 2 Faculty of Biochemistry and Molecular Medicine & Biocenter Oulu, University of Oulu, Aapistie 7A, FI-90220 Oulu, Finland; [email protected] * Correspondence: [email protected] Abstract: Myelin protein zero (P0), a type I transmembrane protein, is the most abundant protein in peripheral nervous system (PNS) myelin – the lipid-rich, periodic structure that concentrically encloses long axonal segments. Schwann cells, the myelinating glia of the PNS, express P0 throughout their development until the formation of mature myelin. In the intramyelinic compartment, the immunoglobulin-like domain of P0 bridges apposing membranes together via homophilic adhesion, forming a dense, macroscopic ultrastructure known as the intraperiod line. The C-terminal tail of P0 adheres apposing membranes together in the narrow cytoplasmic compartment of compact myelin, much like myelin basic protein (MBP). In mouse models, the absence of P0, unlike that of MBP or P2, severely disturbs the formation of myelin. Therefore, P0 is the executive molecule of PNS myelin maturation. How and when is P0 trafficked and modified to enable myelin compaction, and how disease mutations that give rise to incurable peripheral neuropathies alter the function of P0, are currently open questions. The potential mechanisms of P0 function in myelination are discussed, providing a foundation for the understanding of mature myelin development and how it derails in peripheral neuropathies.
    [Show full text]
  • ELISA Kit for Hemopexin (HPX)
    SEB986Ra 96 Tests Enzyme-linked Immunosorbent Assay Kit For Hemopexin (HPX) Organism Species: Rattus norvegicus (Rat) Instruction manual FOR IN VITRO AND RESEARCH USE ONLY NOT FOR USE IN CLINICAL DIAGNOSTIC PROCEDURES 11th Edition (Revised in July, 2013) [ INTENDED USE ] The kit is a sandwich enzyme immunoassay for in vitro quantitative measurement of hemopexin in rat serum, plasma and other biological fluids. [ REAGENTS AND MATERIALS PROVIDED ] Reagents Quantity Reagents Quantity Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4 Standard 2 Standard Diluent 1×20mL Detection Reagent A 1×120μL Assay Diluent A 1×12mL Detection Reagent B 1×120μL Assay Diluent B 1×12mL TMB Substrate 1×9mL Stop Solution 1×6mL Wash Buffer (30 × concentrate) 1×20mL Instruction manual 1 [ MATERIALS REQUIRED BUT NOT SUPPLIED ] 1. Microplate reader with 450 ± 10nm filter. 2. Precision single or multi-channel pipettes and disposable tips. 3. Eppendorf Tubes for diluting samples. 4. Deionized or distilled water. 5. Absorbent paper for blotting the microtiter plate. 6. Container for Wash Solution [ STORAGE OF THE KITS ] 1. For unopened kit: All the reagents should be kept according to the labels on vials. The Standard, Detection Reagent A, Detection Reagent B and the 96-well strip plate should be stored at -20oC upon receipt while the others should be at 4 oC. 2. For opened kit: When the kit is opened, the remaining reagents still need to be stored according to the above storage condition. Besides, please return the unused wells to the foil pouch containing the desiccant pack, and reseal along entire edge of zip-seal.
    [Show full text]
  • B Cell Checkpoints in Autoimmune Rheumatic Diseases
    REVIEWS B cell checkpoints in autoimmune rheumatic diseases Samuel J. S. Rubin1,2,3, Michelle S. Bloom1,2,3 and William H. Robinson1,2,3* Abstract | B cells have important functions in the pathogenesis of autoimmune diseases, including autoimmune rheumatic diseases. In addition to producing autoantibodies, B cells contribute to autoimmunity by serving as professional antigen- presenting cells (APCs), producing cytokines, and through additional mechanisms. B cell activation and effector functions are regulated by immune checkpoints, including both activating and inhibitory checkpoint receptors that contribute to the regulation of B cell tolerance, activation, antigen presentation, T cell help, class switching, antibody production and cytokine production. The various activating checkpoint receptors include B cell activating receptors that engage with cognate receptors on T cells or other cells, as well as Toll-like receptors that can provide dual stimulation to B cells via co- engagement with the B cell receptor. Furthermore, various inhibitory checkpoint receptors, including B cell inhibitory receptors, have important functions in regulating B cell development, activation and effector functions. Therapeutically targeting B cell checkpoints represents a promising strategy for the treatment of a variety of autoimmune rheumatic diseases. Antibody- dependent B cells are multifunctional lymphocytes that contribute that serve as precursors to and thereby give rise to acti- cell- mediated cytotoxicity to the pathogenesis of autoimmune diseases
    [Show full text]
  • Activin-A As an Intraovarian Modulator: Actions, Localization, and Regulation of the Intact Dimer in Human Ovarian Cells
    Activin-A as an intraovarian modulator: actions, localization, and regulation of the intact dimer in human ovarian cells. J Rabinovici, … , R Schwall, R B Jaffe J Clin Invest. 1992;89(5):1528-1536. https://doi.org/10.1172/JCI115745. Research Article The actions, localization, and regulation of activin in the human ovary are unknown. Therefore, the aims of this study were (a) to define the effects of recombinant activin-A and its structural homologue, inhibin-A, on mitogenesis and steroidogenesis (progesterone secretion and aromatase activity) in human preovulatory follicular cells; (b) to localize the activin-A dimer in the human ovary by immunohistochemistry; and (c) to examine regulation of intracellular activin-A production in cultured human follicular cells. In addition to stimulating mitogenic activity, activin-A causes a dose- and time-dependent inhibition of basal and gonadotropin-stimulated progesterone secretion and aromatase activity in human luteinizing follicular cells on day 2 and day 4 of culture. Inhibin-A exerts no effects on mitogenesis, basal or gonadotropin- stimulated progesterone secretion and aromatase activity, and does not alter effects observed with activin-A alone. Immunostaining for dimeric activin-A occurs in granulosa and cumulus cells of human ovarian follicles and in granulosa- lutein cells of the human corpus luteum. cAMP, and to a lesser degree human chorionic gonadotropin and follicle- stimulating hormone, but not inhibin-A, activin-A, or phorbol 12-myristate 13-acetate, increased the immunostaining for activin-A in cultured granulosa cells. These results indicate that activin-A may function as an autocrine or paracrine regulator of follicular function in the human ovary.
    [Show full text]
  • Inhibitory Effects of Activin on the Growth and Morphogenesis of Primary and Transformed Mammary Epithelial Cells'
    ICANCERRESEARCH56. I 155-I 163. March I. 19961 Inhibitory Effects of Activin on the Growth and Morphogenesis of Primary and Transformed Mammary Epithelial Cells' Qiu Yan Liu, Birunthi Niranjan, Peter Gomes, Jennifer J. Gomm, Derek Davies, R. Charles Coombes, and Lakjaya Buluwela2 Departments of Medical Oncology (Q. Y. L, P. G.. J. J. G., R. C. C., L B.J and Biochemistry (Q. Y. L. L B.J. Charing Cross and Westminster Medical School, Fuiham Palace Road. London W6 8RF; Division of Cell Biology and Experimental Pathology. Institute of Cancer Research, 15 Cotswald Rood, Sutton. Surrey SM2 SNG (B. NJ; and FACS Analysis Laboratory. imperial Cancer Research Fund, Lincoln ‘sInnFields. London WC2A 3PX (D. DI, United Kingdom ABSTRACT logical activities of activin. Indeed, two types of activin receptors have aLready been identified in the mouse (28) and several forms in Activin Is a member of the transforming growth factor fi superfamily, Xenopus (29, 30). The sequences of the Act-RI! (3 1), the TGF-@ type which is known to have activities Involved In regulating differentiation II receptor (32), the TGF-f3 type I receptor (33), and various activin and development. By using reverse transcrlption.PCR analysis on immu noafflnity.purlfied human breast cells, we have found that activin IJa and receptor-like genes (34) have been described. The comparison of these activin type II receptor are expressed by myoepithelial cells, whereas no sequences shows that they belong to a newly defined family of expression was detected In other breast cell types. In examining 15 breast membrane-bound, ligand-activated serine-threonine kinases (35).
    [Show full text]
  • Production and Purification of Recombinant Human Inhibin and Activin
    199 Production and purification of recombinant human inhibin and activin S A Pangas1 and T K Woodruff1,2 1Department of Neurobiology and Physiology, Northwestern University, Evanston, Illinois 60208, USA 2Department of Medicine, Northwestern University Medical School, Chicago, Illinois 60611, USA (Requests for offprints should be addressed to T K Woodruff; Email: [email protected]) Abstract Inhibin and activin are protein hormones with diverse Conditioned cell media can be purified through column physiological roles including the regulation of pituitary chromatography resulting in dimeric mature 32–34 kDa FSH secretion. Like other members of the transforming inhibin A and 28 kDa activin A. The purified recom- growth factor- gene family, they undergo processing binant proteins maintain their biological activity as from larger precursor molecules as well as assembly into measured by traditional in vitro assays including the regu- functional dimers. Isolation of inhibin and activin from lation of FSH in rat anterior pituitary cultures and the natural sources can only produce limited quantities of regulation of promoter activity of the activin-responsive bioactive protein. To purify large-scale quantities of promoter p3TP-luc in tissue culture cells. These proteins recombinant human inhibin and activin, we have utilized will be valuable for future analysis of inhibin and activin stably transfected cell lines in self-contained bioreactors to function and have been distributed to the US National produce protein. These cells produce approximately Hormone and Peptide Program. 200 µg/ml per day total recombinant human inhibin. Journal of Endocrinology (2002) 172, 199–210 Introduction residues (Dubois et al. 2001, Leitlein et al. 2001). The subtilisin-like proprotein covertases also cleave other Inhibin is a gonadal peptide originally isolated from ovarian TGF- family members such as Mullerian-inhibiting follicular fluid (Ling et al.
    [Show full text]
  • Testicular Expression of Inhibin and Activin Subunits and Follistatin in the Rat and Human Fetus and Neonate and During Postnatal Development in the Rat*
    0013-7227/97/$03.00/0 Vol. 138, No. 5 Endocrinology Printed in U.S.A. Copyright © 1997 by The Endocrine Society Testicular Expression of Inhibin and Activin Subunits and Follistatin in the Rat and Human Fetus and Neonate and During Postnatal Development in the Rat* GREGOR MAJDIC, ALLAN S. MCNEILLY, RICHARD M. SHARPE, LEE R. EVANS, NIGEL P. GROOME, AND PHILIPPA T. K. SAUNDERS Medical Research Council Reproductive Biology Unit (G.M., A.S.M., R.M.S., P.T.K.S.), Edinburgh, EH3 9EW, United Kingdom; and the School of Biological and Molecular Sciences (L.R.E., N.P.G.), Oxford Brookes University, Headington, Oxford, OX3 0BP, United Kingdom ABSTRACT than immunostaining for the a-subunit. The pattern of bB-immuno- Inhibins, activins, and follistatins are all believed to play roles in staining in postnatal samples paralleled that of the a-subunit. Im- the regulation of FSH secretion by the pituitary and in the paracrine munostaining using antibodies against the bA-subunit did not pro- regulation of testis function. Previous studies have resulted in con- duce any significant reaction product in any sample. Follistatin was flicting data on the pattern of expression of the inhibin/activin sub- undetectable in the fetal rat testis but appeared in the Leydig cells units, and little information on expression of follistatin during fetal/ immediately after birth and its expression remained intense through- neonatal life. We have made use of new, highly specific monoclonal out postnatal development and in adult testis. No evidence was ob- antibodies and fixed tissue sections from fetal, neonatal, and adult tained for expression of either the inhibin/activin subunits or follista- rats, and limited amounts of fetal and neonatal human testis, to tin in the germ cells, peritubular myoid cells, or other interstitial cells undertake a detailed immunocytochemical study of the pattern of in any of the sections examined.
    [Show full text]
  • Peripheral Myelin Protein 22 (Pmp22) Is in a Complex with Alpha6 Beta4 Integrin and the Absence of Pmp22 Affects Schwann Cell Adhesion and Migration
    PERIPHERAL MYELIN PROTEIN 22 (PMP22) IS IN A COMPLEX WITH ALPHA6 BETA4 INTEGRIN AND THE ABSENCE OF PMP22 AFFECTS SCHWANN CELL ADHESION AND MIGRATION By STEPHANIE ANN AMICI A DISSERTATION PRESENTED TO THE GRADUATE SCHOOL OF THE UNIVERSITY OF FLORIDA IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY UNIVERSITY OF FLORIDA 2006 Copyright 2006 by Stephanie Ann Amici I dedicate this work to my family for their constant love and support. ACKNOWLEDGMENTS Most importantly, I would like to thank my advisor, Dr. Lucia Notterpek, for the inspiration and support she has given to me. She has always had my best interests in mind and has been essential in my growth as a scientist and as a person. I also express my gratitude to my committee members, Dr. Brad Fletcher, Dr. Dena Howland, Dr. Harry Nick and Dr. Susan Frost, for their insights and suggestions for my project. Similarly, Dr. William Dunn deserves acknowledgement for his advice and assistance with the electron microscopy studies. Heartfelt thanks also go to the past and present members of the Notterpek lab for their amazing friendships over the years. Finally, my deepest gratitude goes to my family, especially my parents, for their continuous love and encouragement throughout my life. iv TABLE OF CONTENTS page ACKNOWLEDGMENTS ................................................................................................. iv LIST OF FIGURES .......................................................................................................... vii LIST OF ABBREVIATIONS...........................................................................................
    [Show full text]
  • A Study of Serum Levels of Inhibin a and B, Pro Alpha-C and Activin a in Women with Ovulatory Disturbances Before and After Stimulation with Gnrh
    European Journal of Endocrinology (2000) 143 77±84 ISSN 0804-4643 CLINICAL STUDY Inverse correlation between baseline inhibin B and FSH after stimulation with GnRH: a study of serum levels of inhibin A and B, pro alpha-C and activin A in women with ovulatory disturbances before and after stimulation with GnRH Fritz W Casper, Rudolf J Seufert1 and Kunhard Pollow Department of Experimental Endocrinology and 1Department of Obstetrics and Gynecology, Johannes Gutenberg University Mainz, D-55101 Mainz, Germany (Correspondence should be addressed to F W Casper, Department of Experimental Endocrinology, Langenbeckstrasse 1, D-55101 Mainz, Germany; Email: [email protected]) Abstract Objective: Interest has focused recently on the in¯uences of the polypeptide factors inhibin and activin on the selective regulation of the pituitary secretion of gonadotropins. Design: Measurement of the concentrations of inhibin-related proteins in relation to the changes in pituitary gonadotropin (FSH, LH) parameters, after GnRH stimulation with a bolus injection of 100 mg gonadorelin, in 19 women with ovulatory disturbances. Methods: Serum levels of inhibin A and B, activin A, and pro alpha-C were measured using sensitive ELISA kits. Results: Within 60 min after GnRH stimulation, FSH values doubled from 5 to 10 mU/ml (P < 0.001). LH increased 12-fold from 2 to 24 mU/ml (P < 0.001). Activin A showed a signi®cant decrease from 0.47 to 0.36 ng/ml (P < 0.001), whereas pro alpha-C increased from 127 to 156 pg/ml (P 0.039). The median inhibin A concentration did not show a signi®cant change between baseline and the 60 min value, whereas inhibin B was characterized by a minor, but not signi®cant, increase in the median from 168 to 179 pg/ml (P 0.408).
    [Show full text]